Risk of cancer in patients treated with recombinant human growth hormone in childhood.

Ann Pediatr Endocrinol Metab · 2019 · PMC6603614 · PMID 31261472

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

This finding was not confirmed in the SAGhE study though a significant trend with longer follow-up (although no trend with GH dose) was observed [ 66 ].

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.